Mechanism of inflammatory cancer-associated fibroblast-mediated drug resistance in colorectal cancer cells

Background and purpose: Colorectal cancer (CRC) is one of the common malignancies, but the mechanism by which it develops resistance to drug remains unclear. The tumor microenvironment (TME), especially cancer-associated fibroblast (CAF), plays an important role in the occurrence, development and dr...

Full description

Bibliographic Details
Main Author: CAI Jialuo, ZHU Ruiqiu, LI Sen, CAO Yijun, HUANG Fang
Format: Article
Language:English
Published: Editorial Office of China Oncology 2023-12-01
Series:Zhongguo aizheng zazhi
Subjects:
Online Access:http://www.china-oncology.com/fileup/1007-3639/PDF/1703749953238-2122322508.pdf
_version_ 1797300327137935360
author CAI Jialuo, ZHU Ruiqiu, LI Sen, CAO Yijun, HUANG Fang
author_facet CAI Jialuo, ZHU Ruiqiu, LI Sen, CAO Yijun, HUANG Fang
author_sort CAI Jialuo, ZHU Ruiqiu, LI Sen, CAO Yijun, HUANG Fang
collection DOAJ
description Background and purpose: Colorectal cancer (CRC) is one of the common malignancies, but the mechanism by which it develops resistance to drug remains unclear. The tumor microenvironment (TME), especially cancer-associated fibroblast (CAF), plays an important role in the occurrence, development and drug resistance of tumors. This study aimed to investigate the effect of inflammatory cancer-associated fibroblasts (iCAF) on drug resistance in CRC cells and its possible mechanism. Methods: The primary CAFs were collected from CRC patients underwent surgery in Putuo Hospital, Shanghai University of Traditional Chinese Medicine from Aug. 2022 to Sep. 2022, and the primary cells were sorted according to the surface marker of CAF[approved by the Ethics Committee of Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine: PTEC-A-2023-5(S)-1], platelet derived growth factor receptor alpha (PDGFRA), to screen iCAF. Human intestinal fibroblast (HIF) and iCAF cells were cultured using serum-free medium to obtain conditioned medium. According to the treatment method, colon cancer cells were divided into control group (no treatment), experimental group 1(treated with HIF-CM) and experimental group 2 (treated with iCAF-CM). We observed the changes in the survival rate and apoptotic rate of CRC cells, the changes in protein and mRNA levels and the effect on the Wnt/β-catenin signaling pathway after stimulation with HIF-CM or iCAF-CM. Results: After iCAFs stimulation, the half inhibition concentration (IC50) of CRC cells was higher compared with the control group and HIF-CM group (P<0.05). Compared with the control group and HIF-CM group, the apoptotic rate of tumor cells in iCAF-CM group decreased significantly, the expression of caspase-3 was decreased, and the expressions of Bcl-2, Bcl-xL and survivin were increased (P<0.05). The Wnt/β-catenin signaling pathway was activated in the iCAF-CM group. Conclusion: iCAFs can mediate drug resistance in CRC cells, and the mechanism is related to the activation of Wnt/β-catenin signaling pathway.
first_indexed 2024-03-07T23:04:40Z
format Article
id doaj.art-fcc35bc7accc4bc49be93710425b4be0
institution Directory Open Access Journal
issn 1007-3639
language English
last_indexed 2024-03-07T23:04:40Z
publishDate 2023-12-01
publisher Editorial Office of China Oncology
record_format Article
series Zhongguo aizheng zazhi
spelling doaj.art-fcc35bc7accc4bc49be93710425b4be02024-02-22T06:28:33ZengEditorial Office of China OncologyZhongguo aizheng zazhi1007-36392023-12-0133121065107210.19401/j.cnki.1007-3639.2023.12.001Mechanism of inflammatory cancer-associated fibroblast-mediated drug resistance in colorectal cancer cellsCAI Jialuo, ZHU Ruiqiu, LI Sen, CAO Yijun, HUANG Fang01. Department of General Surgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China;2. School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China;3. Shanghai Putuo Central School of Clinical Medicine, Anhui Medical University, Shanghai 200062, China;4. Department of Pathology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, ChinaBackground and purpose: Colorectal cancer (CRC) is one of the common malignancies, but the mechanism by which it develops resistance to drug remains unclear. The tumor microenvironment (TME), especially cancer-associated fibroblast (CAF), plays an important role in the occurrence, development and drug resistance of tumors. This study aimed to investigate the effect of inflammatory cancer-associated fibroblasts (iCAF) on drug resistance in CRC cells and its possible mechanism. Methods: The primary CAFs were collected from CRC patients underwent surgery in Putuo Hospital, Shanghai University of Traditional Chinese Medicine from Aug. 2022 to Sep. 2022, and the primary cells were sorted according to the surface marker of CAF[approved by the Ethics Committee of Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine: PTEC-A-2023-5(S)-1], platelet derived growth factor receptor alpha (PDGFRA), to screen iCAF. Human intestinal fibroblast (HIF) and iCAF cells were cultured using serum-free medium to obtain conditioned medium. According to the treatment method, colon cancer cells were divided into control group (no treatment), experimental group 1(treated with HIF-CM) and experimental group 2 (treated with iCAF-CM). We observed the changes in the survival rate and apoptotic rate of CRC cells, the changes in protein and mRNA levels and the effect on the Wnt/β-catenin signaling pathway after stimulation with HIF-CM or iCAF-CM. Results: After iCAFs stimulation, the half inhibition concentration (IC50) of CRC cells was higher compared with the control group and HIF-CM group (P<0.05). Compared with the control group and HIF-CM group, the apoptotic rate of tumor cells in iCAF-CM group decreased significantly, the expression of caspase-3 was decreased, and the expressions of Bcl-2, Bcl-xL and survivin were increased (P<0.05). The Wnt/β-catenin signaling pathway was activated in the iCAF-CM group. Conclusion: iCAFs can mediate drug resistance in CRC cells, and the mechanism is related to the activation of Wnt/β-catenin signaling pathway.http://www.china-oncology.com/fileup/1007-3639/PDF/1703749953238-2122322508.pdf|colorectal cancer|inflammatory cancer-associated fibroblasts|drug resistance|wnt/β-catenin signaling pathway
spellingShingle CAI Jialuo, ZHU Ruiqiu, LI Sen, CAO Yijun, HUANG Fang
Mechanism of inflammatory cancer-associated fibroblast-mediated drug resistance in colorectal cancer cells
Zhongguo aizheng zazhi
|colorectal cancer|inflammatory cancer-associated fibroblasts|drug resistance|wnt/β-catenin signaling pathway
title Mechanism of inflammatory cancer-associated fibroblast-mediated drug resistance in colorectal cancer cells
title_full Mechanism of inflammatory cancer-associated fibroblast-mediated drug resistance in colorectal cancer cells
title_fullStr Mechanism of inflammatory cancer-associated fibroblast-mediated drug resistance in colorectal cancer cells
title_full_unstemmed Mechanism of inflammatory cancer-associated fibroblast-mediated drug resistance in colorectal cancer cells
title_short Mechanism of inflammatory cancer-associated fibroblast-mediated drug resistance in colorectal cancer cells
title_sort mechanism of inflammatory cancer associated fibroblast mediated drug resistance in colorectal cancer cells
topic |colorectal cancer|inflammatory cancer-associated fibroblasts|drug resistance|wnt/β-catenin signaling pathway
url http://www.china-oncology.com/fileup/1007-3639/PDF/1703749953238-2122322508.pdf
work_keys_str_mv AT caijialuozhuruiqiulisencaoyijunhuangfang mechanismofinflammatorycancerassociatedfibroblastmediateddrugresistanceincolorectalcancercells